Download Free Sample Report

Hemoglobinopathy Testing Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hemoglobinopathy Testing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

• Hydroxyurea
• Glutamine
• Zynteglo
• Luspatercept
• Others

Segment by Application

• Sickle Cell Diseases
• Thalassemia
• Other

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

By Company

• Novartis
• AstraZeneca
• Bluebird Bio
• Bristol-Myers Squibb
• Emmaus Medical
• Acceleron Pharma
• HemaQuest Pharmaceuticals
• Eli Lilly and Company
• Celgene Corporation